论文部分内容阅读
目的观察阿德福韦酯治疗乙型肝炎肝硬化并肝源性糖尿病的疗效。方法对39例乙型肝炎肝硬化合并肝源性糖尿病患者临床病情特点,糖尿病病情与肝功能分级的关系,及使用阿德福韦酯10 mg口服1次/d治疗36周后,对临床病情的影响进行了回顾分析。结果经阿德福韦酯等综合治疗后,患者肝功能有明显好转,血糖水平亦可控制。结论治疗36周后患者HBV-DNA水平明显下降,还使肝功能良好恢复,糖尿病亦得到控制,且安全性和耐受性好。
Objective To observe the curative effect of adefovir dipivoxil on hepatitis B cirrhosis and liver-derived diabetes mellitus. Methods The clinical characteristics of 39 patients with hepatitis B cirrhosis complicated with liver-derived diabetes, the relationship between diabetes and the grading of liver function, and the use of adefovir dipivoxil 10 mg once a day for 36 weeks, The impact of a retrospective analysis. Results After adefovir dipivoxil and other comprehensive treatment, patients with liver function improved significantly, blood glucose levels can be controlled. Conclusions After 36 weeks of treatment, the level of HBV-DNA in patients is significantly decreased, the liver function is well recovered, the diabetes is also controlled, and the safety and tolerability are good.